| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |